• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Satoshi Hirase, Daiichiro Hasegawa, +14 authors Yoshiyuki Kosaka
  • Medicine
  • International Journal of Hematology
  • 2015 (First Published: 1 November 2015)
  • Recent studies have reported that the absolute lymphocyte count (ALC) during induction therapy is predictive of treatment outcome in de novo acute lymphoblastic leukemia (ALL); however, theContinue Reading
  • Akihiro Tamura, Toshiaki Ishida, +11 authors Yoshiyuki Kosaka
  • Medicine
  • Pediatric blood & cancer
  • 2018 (First Published: 1 October 2018)
  • The dismal prognosis of pediatric acute myeloid leukemia (AML) relapsing after hematopoietic stem cell transplantation (HSCT) requires exploration of novel strategies to prevent relapse. AzacitidineContinue Reading
  • Kenji Kishimoto, Keiichiro Kawasaki, +4 authors Yoshiyuki Kosaka
  • Medicine
  • Pediatric blood & cancer
  • 2017 (First Published: 1 September 2017)
  • BACKGROUND Optimal prevention of chemotherapy-induced vomiting (CIV) has not been established for patients receiving cisplatin in divided doses. The aim of this study was to describe the incidenceContinue Reading
  • N. Paul Niño, Aiko Kozaki, +14 authors Yoshiyuki Kosaka
  • Medicine
  • [Rinsho ketsueki] The Japanese journal of…
  • 2016 (First Published: 1 June 2016)
  • We herein describe a 2-year-old boy with severe congenital neutropenia (SCN) who was successfully treated with reduced-intensity bone marrow transplantation (HSCT). He had suffered recurrent episodesContinue Reading
  • Khin Kyae Mon Thwin, Toshiaki Ishida, +13 authors Noriyuki Nishimura
  • Medicine
  • The Journal of molecular diagnostics : JMD
  • 2019 (First Published: 11 December 2019)
  • Monitoring of several sets of neuroblastoma-associated mRNAs (NB-mRNAs) by quantitative PCR (qPCR) can be used for evaluating minimal residual disease (MRD) in neuroblastoma (NB) patients. DropletContinue Reading